Figures computed from official regulatory filings — .
Analysttarget 9.5 USD (+366%) · consensus 5/5 · 1 buy · 0 hold · 0 sell
Ownershipinsiders 50.75% · institutions 5.55% · short 0.5% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Serina Therapeutics, Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Serina Therapeutics, Inc., a biotechnology company, develops drugs to treat neurological diseases and pain. Its lead product candidate is SER 252 (POZ-apomorphine), a POZ conjugate for the treatment of advanced Parkinson's disease that is in phase 1 clinical trial; and POZ-lipids, a non-immunogenic alternative to the PEG-lipids in the lipid nanoparticles. The company also develops SER 214, a POZ conjugate of rotigotine for the treatment of early Parkinson's and Restless Leg Syndrome, which has completed phase 1a clinical trial. In addition, it develops POZ technology in lipid nanoparticle delivered ribonucleic acid vaccines for infectious diseases. It has a partnership agreement with Gannet BioChem to support development activities for SER-252. Serina Therapeutics, Inc. was founded in 2006 and is headquartered in Huntsville, Alabama.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
37 buys41 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| Simon Farrell | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Brannan Stephen K. | Buy | $2K | conv 63ClusterFirst in 12mo | SEC |
| Bailey Gregorytrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Brannan Stephen K. | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Venkatesan Jaytrack record | OtherD (derivative) | $217.2K | SEC |
| Venkatesan Jaytrack record | Buy | $1K | conv 49ClusterFirst in 12mo | SEC |
| Venkatesan Jaytrack record | Other | $504.3K | SEC |
| Bailey Gregorytrack record | Other | $4M | SEC |
| Bailey Gregorytrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Bailey Gregorytrack record | OtherD (derivative) | $1.7M | SEC |
| Bailey Gregorytrack record | Other | $15M | SEC |
| Marshall Richard Peter | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Venkatesan Jaytrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| WILSON KAREN J | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| WILSON KAREN J | Buy | $8.9K | conv 55Cluster | SEC |
| WILSON KAREN J | Buy | $8.9K | conv 52Cluster | SEC |
| LEDGER STEVEN A | Award | $19.5K | SEC |
| WILSON KAREN J | Buy | $19.3K | conv 66Cluster | SEC |
| LEDGER STEVEN A | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| WILSON KAREN J | Buy | $17.7K | conv 61First in 12mo | SEC |
| CURHAN GREGORY Strack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Tenjarla Srini | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Moreadith Randall | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Marshall Richard Peter | Buy | $20.1K | conv 83First in 12mo | SEC |
| Venkatesan Jaytrack record | Award | $14.7K | SEC |